PubRank

Kazuo Tamura

Author PubWeight™ 78.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002 2.71
2 Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol 2010 2.64
3 Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis. J Clin Oncol 2006 2.53
4 VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 2007 1.79
5 Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma. J Clin Oncol 2012 1.62
6 Epstein-Barr virus genome level, T-cell clonality and the prognosis of angioimmunoblastic T-cell lymphoma. Haematologica 2005 1.52
7 Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma. J Clin Oncol 2014 1.39
8 Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively. Immunogenetics 2002 1.25
9 Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis. Blood 2005 1.23
10 Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era. Cancer Sci 2009 1.22
11 Treatment of adult T-cell leukemia/lymphoma: past, present, and future. Eur J Haematol 2007 1.17
12 Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era. Cancer 2011 1.13
13 Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas. J Pathol 2004 1.10
14 Germline mutations of the MYH gene in Japanese patients with multiple colorectal adenomas. Mutat Res 2005 1.08
15 Attenuated antibody reaction for the primary antigen but not for the recall antigen of influenza vaccination in patients with non-Hodgkin B-cell lymphoma after the administration of rituximab-CHOP. J Clin Exp Hematop 2009 1.05
16 Surgical management of adult sigmoid colon intussusception caused by a malignant tumor: report of a case. Surg Today 2003 1.01
17 Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era. Cancer Sci 2011 1.00
18 Imatinib mesylate inhibits cell invasion of malignant peripheral nerve sheath tumor induced by platelet-derived growth factor-BB. Lab Invest 2007 0.99
19 Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma. Leuk Lymphoma 2009 0.98
20 Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF/Endo G pathway. Oncogene 2005 0.97
21 A clinical overview of familial adenomatous polyposis derived from the database of the Polyposis Registry of Japan. Int J Clin Oncol 2004 0.96
22 p38 mitogen-activated protein kinase inhibitor LY2228820 enhances bortezomib-induced cytotoxicity and inhibits osteoclastogenesis in multiple myeloma; therapeutic implications. Br J Haematol 2008 0.96
23 Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy. Support Care Cancer 2015 0.92
24 Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults. Int J Oncol 2004 0.92
25 Vancomycin bactericidal activity as a predictor of 30-day mortality in patients with methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2011 0.91
26 Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A). Br J Haematol 2014 0.91
27 Pleural malignant mesothelioma with invasive micropapillary component and its association with pulmonary metastasis. Pathol Int 2009 0.89
28 Therapeutic potential of arsenic trioxide with or without interferon-alpha for relapsed/refractory adult T-cell leukemia/lymphoma. Haematologica 2007 0.87
29 Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: in vitro and in vivo effects of the novel Bcl-2 family inhibitor ABT-737. Cancer Lett 2011 0.87
30 Coexistent anaplastic and differentiated thyroid carcinoma: an immunohistochemical study. Am J Clin Pathol 2006 0.86
31 Safety and pharmacokinetic evaluation of repeated intravenous administration of palonosetron 0.75 mg in patients receiving highly or moderately emetogenic chemotherapy. Support Care Cancer 2014 0.86
32 First reported case of hemoglobin lansing in Asia detected by false low oxygen saturation on pulse oximetry. Int J Hematol 2012 0.85
33 Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever. Int J Antimicrob Agents 2005 0.83
34 Targeting CD56 by the maytansinoid immunoconjugate IMGN901 (huN901-DM1): a potential therapeutic modality implication against natural killer/T cell malignancy. Br J Haematol 2008 0.83
35 Presence of both heterogeneous vancomycin-intermediate resistance and β-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection. Scand J Infect Dis 2012 0.83
36 Beta-cell function is a major contributor to oral glucose disposition in obese Japanese students. Endocr J 2007 0.82
37 Birt-Hogg-Dubé syndrome and familial adenomatous polyposis: an association or a coincidence? Intern Med 2012 0.82
38 Smouldering adult T-cell leukaemia/lymphoma: a follow-up study in Kyushu. Br J Haematol 2008 0.82
39 Determination of splice-site mutations in Lynch syndrome (hereditary non-polyposis colorectal cancer) patients using functional splicing assay. Fam Cancer 2009 0.82
40 Osteosarcoma of the patella mimicking giant cell tumor: imaging features with histopathological correlation. Anticancer Res 2014 0.82
41 Antitumor effects of CRM197, a specific inhibitor of HB-EGF, in T-cell acute lymphoblastic leukemia. Anticancer Res 2011 0.81
42 Oncogene associated cDNA microarray analysis shows PRAME gene expression is a marker for response to anthracycline containing chemotherapy in patients with diffuse large B-cell lymphoma. J Clin Exp Hematop 2009 0.81
43 Rapid and sensitive HPLC method for the simultaneous determination of paraquat and diquat in human serum. Anal Sci 2007 0.81
44 Phase II study of weekly paclitaxel for advanced or metastatic breast cancer in Japan. Anticancer Res 2009 0.81
45 THP-COP regimen for the treatment of peripheral T-cell lymphoma and adult T-cell leukemia/lymphoma: a multicenter phase II study. Eur J Haematol 2010 0.81
46 Administration of chemotherapy via the median cubital vein without implantable central venous access ports: port-free chemotherapy for metastatic colorectal cancer patients. Int J Clin Oncol 2014 0.81
47 Population pharmacokinetic study of a test dose oral busulfan in Japanese adult patients undergoing hematopoietic stem cell transplantation. Cancer Chemother Pharmacol 2010 0.80
48 Primary colorectal T-cell lymphoma. J Gastroenterol 2003 0.80
49 A patient with acute myeloid leukemia who developed fatal pneumonia caused by carbapenem-resistant Bacillus cereus. J Infect Chemother 2009 0.80
50 Phase II study of cladribine (2-chlorodeoxyadenosine) in relapsed or refractory adult T-cell leukemia-lymphoma. Int J Hematol 2003 0.80
51 Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan: a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group. Int J Hematol 2010 0.80
52 [High dose ara-C therapy induced bradycardia in an acute myeloid leukemia patient with inv (16)(p13q22)]. Rinsho Ketsueki 2003 0.79
53 Desmoplastic small round cell tumors in a young man. Intern Med 2013 0.79
54 The prophylactic effect of itraconazole capsules and fluconazole capsules for systemic fungal infections in patients with acute myeloid leukemia and myelodysplastic syndromes: a Japanese multicenter randomized, controlled study. Int J Hematol 2007 0.79
55 Mucinous carcinoma of the duodenum associated with hereditary nonpolyposis colorectal cancer: report of a case. Surg Today 2006 0.79
56 Dose response of pegfilgrastim in Japanese breast cancer patients receiving six cycles of docetaxel, doxorubicin, and cyclophosphamide therapy: a randomized controlled trial. Support Care Cancer 2015 0.79
57 Cladribine treatment in two-hour intravenous infusion for previously-treated low grade B-cell lymphoma: a pilot study. J Clin Exp Hematop 2009 0.79
58 RARalpha is a regulatory factor for Am-80-induced cell growth inhibition of hematologic malignant cells. Int J Oncol 2007 0.79
59 Mature T/NK-cell lymphoproliferative disease and Epstein-Barr virus infection are more frequent in patients with rheumatoid arthritis treated with methotrexate. Virchows Arch 2013 0.79
60 Disturbance of the growth hormone-insulin-like growth factor-1 axis associated with poor performance status in patients with solid tumors. Jpn J Clin Oncol 2009 0.78
61 Efficacy and safety of micafungin as an empirical antifungal therapy for suspected fungal infection in neutropenic patients with hematological disorders. Ann Hematol 2011 0.77
62 Dosage of capecitabine and cyclophosphamide combination therapy in patients with metastatic breast cancer. Anticancer Res 2007 0.77
63 [A novel genetic disorder of Lynch syndrome - EPCAM gene deletion]. Gan To Kagaku Ryoho 2013 0.77
64 Bortezomib, doxorubicin and intermediate-dose dexamethasone (iPAD) therapy for relapsed or refractory multiple myeloma: a multicenter phase 2 study. Int J Hematol 2013 0.77
65 Alterations of the base excision repair gene MUTYH in sporadic colorectal cancer. Oncol Rep 2012 0.77
66 A phase I study of bortezomib in combination with doxorubicin and intermediate-dose dexamethasone (iPAD therapy) for relapsed or refractory multiple myeloma. Int J Hematol 2010 0.77
67 Screening of promising chemotherapeutic candidates from plants against human adult T-cell leukemia/lymphoma (IV): phenanthroindolizidine alkaloids from Tylophora tanakae leaves. J Nat Med 2015 0.77
68 Serum vitamin C levels in type 2 diabetic nephropathy. Diabetes Care 2005 0.76
69 Prospective randomized study of cefepime, panipenem, or meropenem monotherapy for patients with hematological disorders and febrile neutropenia. J Infect Chemother 2012 0.76
70 Interferon-α and zidovudine for relapsed/refractory adult T cell leukemia/lymphoma: case reports of Japanese patients. Int J Hematol 2010 0.76
71 Importance of inducible multidrug resistance 1 expression in HL-60 cells resistant to gemtuzumab ozogamicin. Leuk Lymphoma 2012 0.76
72 Evaluation of regional cerebral glucose metabolism in patients with malignant lymphoma of the body using statistical image analysis. Ann Nucl Med 2014 0.76
73 [Extranodal NK/T-cell lymphoma arising from soft tissue of the left forearm]. Rinsho Ketsueki 2010 0.76
74 Docetaxel/irinotecan combination chemotherapy in platinum/taxane-refractory and -resistant ovarian cancer: JGOG/WJGOG Intergroup Study. Int J Clin Oncol 2011 0.76
75 Expression and role of GLUT-1, MCT-1, and MCT-4 in malignant pleural mesothelioma. Virchows Arch 2012 0.76
76 Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: a phase II study. Anticancer Drugs 2010 0.76
77 Methicillin-resistant Staphylococcus aureus bloodstream infections in a Japanese University Hospital between 1987 and 2004. J Infect Chemother 2011 0.76
78 Screening of promising chemotherapeutic candidates from plants against human adult T-cell leukemia/lymphoma (II): apoptosis of antiproliferactive principle (24,25-dihydrowithanolide D) against ATL cell lines and structure-activity relationships with withanolides isolated from solanaceous plants. J Nat Med 2012 0.76
79 Am80 inhibits stromal cell-derived factor-1-induced chemotaxis in T-cell acute lymphoblastic leukemia cells. Leuk Lymphoma 2010 0.76
80 An evaluation of busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation. Jpn J Clin Oncol 2005 0.76
81 Neoadjuvant epirubicin/docetaxel (ET) concomitant chemotherapy for primary breast cancer with tumor diameter >=3.1 cm: results of the Kyushu ET therapy phase II trial. Anticancer Res 2012 0.76
82 Screening of promising chemotherapeutic candidates against human adult T-cell leukemia/lymphoma from plants: active principles from Physalis pruinosa and structure-activity relationships with withanolides. J Nat Med 2011 0.76
83 Screening of promising chemotherapeutic candidates from plants against human adult T-cell leukemia/lymphoma (III). J Nat Med 2013 0.76
84 Simple and sensitive HPLC method for the fluorometric determination of methotrexate and its major metabolites in human plasma by post-column photochemical reaction. Biomed Chromatogr 2011 0.75
85 Empirical voriconazole therapy for febrile neutropenic patients with hematological disorders: a prospective multicenter trial in Japan. J Infect Chemother 2013 0.75
86 Simultaneous determination of cytosine arabinoside and its metabolite, uracil arabinoside, in human plasma using hydrophilic interaction liquid chromatography with UV detection. Biomed Chromatogr 2013 0.75
87 [Docetaxel in combination with epirubicin as the first-line chemotherapy for advanced and recurrent breast cancer: a multicenter phase II study]. Gan To Kagaku Ryoho 2012 0.75
88 [Pilot study-previously treated advanced non-small cell lung cancer]. Gan To Kagaku Ryoho 2004 0.75
89 Thrombocytopenia in association with splenomegaly during granulocyte-colony-stimulating factor treatment in mice is not caused by hypersplenism and is resolved spontaneously. Transfusion 2007 0.75
90 [Antibiotic therapy for patients with neutropenia]. Nihon Naika Gakkai Zasshi 2006 0.75
91 [A case of acute respiratory distress syndrome caused by cryptococcus and cytomegalovirus co-infection after Cushing's syndrome treatment]. Kansenshogaku Zasshi 2013 0.75
92 [A multicenter study of epirubicin-docetaxel(ET)as primary chemotherapy for patients with inflammatory breast cancer(IBC)]. Gan To Kagaku Ryoho 2012 0.75
93 Retrospective Analysis of Treatment Outcomes and Geriatric Assessment in Elderly Malignant Lymphoma Patients. J Clin Exp Hematop 2016 0.75
94 A historical perspective on familial cancer: results and vision of the Polyposis Center Project. Int J Clin Oncol 2004 0.75
95 [Febrile neutropenia]. Rinsho Ketsueki 2007 0.75
96 [System of training physicians specializing in cancer chemotherapy]. Nihon Naika Gakkai Zasshi 2009 0.75
97 [Effect of weekly paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide as neoadjuvant treatment for patients with triple-negative and luminal-type breast cancer - a multicenter study]. Gan To Kagaku Ryoho 2015 0.75
98 [Registration of hematological disorders by the Kyushu Hematology Organization for Treatment (K-HOT) Study Group]. Rinsho Ketsueki 2004 0.75
99 [Side effects of chemotherapy]. Nihon Rinsho 2015 0.75
100 Dose escalation study of epirubicin and docetaxel in patients with advanced or recurrent breast cancer. Chemotherapy 2008 0.75
101 Paclitaxel as a first-line chemotherapy for Japanese women with advanced or recurrent breast cancer: a multi-institutional practice-based study by the Kyushu Breast Cancer Study Group (KBC-SG). Breast Cancer 2009 0.75
102 [Legionnaires' disease asssociated with meningitis and cerebellar ataxia]. Nihon Naika Gakkai Zasshi 2006 0.75
103 Efficacy of intravenous ciprofloxacin in patients with febrile neutropenia refractory to initial therapy. Leuk Lymphoma 2006 0.75
104 [Gene testing of hereditary cancer on comprehensive gene medical examination support system]. Gan To Kagaku Ryoho 2005 0.75
105 Concomitant adenocarcinoma and colonic non-Hodgkin's lymphoma in a patient with ulcerative colitis: a case report and molecular analysis. Pathol Res Pract 2010 0.75
106 Weekly paclitaxel in the treatment of advanced or metastatic breast cancer previously treated or not treated with docetaxel: a phase II study. Chemotherapy 2005 0.75
107 [Adjuvant epirubicin and cyclophosphamide followed by weekly paclitaxel for Japanese women with node-positive breast cancer: a multi-institutional feasibility study]. Gan To Kagaku Ryoho 2008 0.75
108 Efficacy and safety of doripenem for sepsis with neutropenia in Japanese patients with hematologic diseases. Jpn J Antibiot 2012 0.75
109 [Management of febrile neutropenic patients]. Gan To Kagaku Ryoho 2006 0.75
110 [Survey on Information Sharing and Approaches to Cooperation between Hospitals and Community Pharmacies in the Care of Outpatients Receiving Chemotherapy]. Gan To Kagaku Ryoho 2016 0.75
111 Executive Summary of Japanese Domestic Guidelines for Management of Deep-seated Mycosis 2014. Med Mycol J 2016 0.75
112 Bone marrow necrosis in a patient with acute promyelocytic leukemia during re-induction therapy with arsenic trioxide. Eur J Haematol 2004 0.75
113 [A phase III study of the efficacy and safety of meropenem in patients with febrile neutropenia]. Jpn J Antibiot 2012 0.75
114 [Exploration of the Factors Influencing Multi-Drug Cancer Chemotherapy in the Elderly - A Retrospective Study]. Gan To Kagaku Ryoho 2016 0.75
115 Optimal treatment schedule of meropenem for adult patients with febrile neutropenia based on pharmacokinetic-pharmacodynamic analysis. J Infect Chemother 2011 0.75
116 [Concept and clinical study of sepsis]. Nihon Naika Gakkai Zasshi 2005 0.75
117 Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to Trastuzumab. Oncology 2017 0.75
118 [Ambulatory chemotherapy in the Fukuoka University hospital]. Gan To Kagaku Ryoho 2006 0.75
119 Pregnancy complicated with pure red cell aplasia: a case report. J Perinat Med 2003 0.75
120 Adjuvant therapy for breast cancer in Kyushu. Breast Cancer 2006 0.75
121 [Hypersomnia as a presentation of paraneoplastic limbic encephalitis in a patient with adult T cell leukemia/lymphoma]. Nihon Naika Gakkai Zasshi 2008 0.75
122 [A study of the sialogogic effect of cevimeline gargle]. Gan To Kagaku Ryoho 2013 0.75
123 [Intracranial extramedullary hematopoiesis following bilateral chronic subdural hematoma in a patient with idiopathic myelofibrosis]. Rinsho Ketsueki 2005 0.75
124 Individual dose adjustment of oral busulfan using a test dose in hematopoietic stem cell transplantation. Int J Hematol 2007 0.75
125 [Adjuvant doxorubicin and cyclophosphamide followed by weekly paclitaxel for Japanese women with node-positive breast cancer: a multi-institutional feasibility study in a variety of practice settings in Kyushu]. Gan To Kagaku Ryoho 2006 0.75
126 Analysis of Candida glabrata strains with reduced sensitivity to micafungin in vitro isolated from a patient with persistent Candidemia. Jpn J Infect Dis 2010 0.75
127 Primary central nervous system lymphoma: the clinical features and treatment of 22 cases. Intern Med 2002 0.75
128 Phase I study of the combination of irinotecan hydrochloride, carboplatin, and dexamethasone for the treatment of relapsed or refractory malignant lymphoma. Int J Hematol 2004 0.75
129 Development of an integrated support system for hereditary cancer and its impact on gynecologic services. Int J Clin Oncol 2013 0.75
130 [Infection control for the treatment of hematological malignancies: a survey of the Kyushu Hematology Organization for Treatment Study Group (K-HOT)]. Rinsho Ketsueki 2003 0.75
131 [Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer]. Rinsho Ketsueki 2009 0.75
132 Efficacy and toxicity of vinorelbine with doxorubicin/cyclophosphamide combination chemotherapy in a phase I-II study for advanced or recurrent breast cancer patients. Breast Cancer 2006 0.75
133 [A successful treatment of progressive necrotizing myositis caused by Aeromonas veronii biotype sobria]. Kansenshogaku Zasshi 2003 0.75
134 [Chemoprevention for Familial Adenomatous Polyposis]. Gan To Kagaku Ryoho 2015 0.75
135 [Treatment of Hodgkin's lymphoma]. Nihon Rinsho 2007 0.75
136 [The survey for anti-emetic guideline by using questioner]. Gan To Kagaku Ryoho 2015 0.75